Tech Company Financing Transactions

Esprit Pharma Funding Round

Esprit Pharma secured a $90 million Series B funding round on 8/2/2006. Investors included Apax Partners, Domain Associates and Greenspring Global Partners.

Transaction Overview

Company Name
Announced On
8/2/2006
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Series B
Proceeds Purpose
This financing improves the financial health and prospects of Esprit to further drive growth and stay on course with our commitment to achieving pre-eminence in the urology and women's health care specialty markets.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2 Tower Center Boulevard
East Brunswick, NJ 08816
USA
Email Address
Not Recorded
Overview
Esprit Pharma is a privately held, niche-oriented pharmaceutical company located in East Brunswick, NJ, committed to improving patient outcomes and well-being within the urology and women's healthcare fields.
Profile
Esprit Pharma LinkedIn Company Profile
Social Media
Esprit Pharma Company Twitter Account
Company News
Esprit Pharma News
Facebook
Esprit Pharma on Facebook
YouTube
Esprit Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Spitznagel
  John Spitznagel LinkedIn Profile  John Spitznagel Twitter Account  John Spitznagel News  John Spitznagel on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/2/2006: Biodel venture capital transaction
Next: 8/2/2006: Acceleron Pharma venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary